Web5 WARNINGS AND PRECAUTIONS . 5.1 Suicidal Behavior and Ideation . 5.2 Dizziness and Ataxia . 5.3 Cardiac Rhythm and C onduction Abnormalities . 5.4 Syncope . 5.5 Withdrawal … WebJan 12, 2024 · Increase the risk of suicidal thoughts or behavior; monitor for the emergence or worsening of depression, suicidal... Dizziness and ataxia reported; may impair ability to …
Lacosamide: Generic, Uses, Side Effects, Dosages, …
WebFeb 27, 2024 · Cautions for Lacosamide Contraindications None. Warnings/Precautions Sensitivity Reactions Multi-organ Hypersensitivity Multi-organ hypersensitivity (also known as drug reaction with eosinophilia and systemic symptoms [DRESS]) reported with other anticonvulsants; can be fatal or life-threatening. WebOct 14, 2024 · skin rash, fever, swollen glands, muscle aches, severe weakness, unusual bruising, yellowing of your skin or eyes ( jaundice ), mood or behavior changes, depression, anxiety, panic attacks, trouble sleeping, impulsive behavior, irritableness, agitation, hostile or aggressive behavior, restlessness, hyperactive (mentally or physically), stal willig abcoude
Lacosamide - Wikipedia
WebOct 14, 2024 · Vimpat may cause serious side effects including: skin rash, fever, swollen glands, muscle aches, severe weakness, unusual bruising, yellowing of your skin or eyes ( jaundice ), mood or behavior changes, depression, anxiety, panic attacks, trouble sleeping, impulsive behavior, irritableness, agitation, hostile or aggressive behavior, restlessness, WebWhen discontinuing therapy, withdraw lacosamide gradually over at least 1 week. Infants, Children, and Adolescents 1 month to 16 years weighing 6 to 29 kg 1 mg/kg/dose IV twice daily initially; may increase by 2 mg/kg/day at weekly intervals based on response and tolerability. The recommended maintenance dose is 3 to 6 mg/kg/dose IV twice daily. WebFeb 22, 2024 · Lacosamide is approved for use: Alone or with other seizure medicines to treat focal (partial) seizures in adults and children 4 years of age or older. As a liquid for injection in people with focal (partial) seizures 17 years and older for temporary use when a person is unable to take an oral form. stal wilfred harke